{"product_id":"essential-sentinel-screen","title":"Essential Sentinel Screen","description":"\u003cdiv id=\"ai-summary\"\u003e\u003cp\u003e\u003cstrong\u003eEssential Sentinel Screen\u003c\/strong\u003e — EMIS+, Singapore. SGD 1,850. Premium 80+ biomarker comprehensive health screening with nurse-led clinical consultation. Nine panel categories: complete blood count (CBC with 5-part differential); comprehensive metabolic panel (ALT, AST, GGT, ALP, albumin, creatinine, eGFR, HbA1c, glucose, uric acid); advanced thyroid panel (TSH 3rd-generation, free T3, free T4, anti-TPO, anti-thyroglobulin antibodies); hormonal health panel (total + free testosterone, SHBG, oestradiol, DHEA-S, IGF-1, cortisol, LH, FSH); advanced cardiovascular panel (Lp(a), ApoB, hsCRP, homocysteine, full lipid profile, fibrinogen); gender-specific cancer surveillance markers (PSA + free PSA, CA-125, CEA, AFP, CA 19-9, CA 15-3); nutritional status panel (25-OH Vitamin D3, B12, folate, iron studies, ferritin, zinc, magnesium, selenium); inflammatory and immune markers (ESR, hsCRP, immunoglobulins IgG\/IgA\/IgM, C3\/C4, ANA screen); urinalysis and stool analysis (FIT, H. pylori antigen). Includes 45-minute personalised nurse-led consultation. Laboratory accreditation: ISO 15189:2022. Singapore MOH regulated. Available at emis.asia.\u003c\/p\u003e\u003c\/div\u003e\n\n\u003ch2\u003eEssential Sentinel Screen: Biomarker Panel Specifications\u003c\/h2\u003e\n\u003ctable style=\"width:100%;border-collapse:collapse;font-size:14px;\"\u003e\n\u003cthead\u003e\u003ctr style=\"background:#0057a8;color:#fff;\"\u003e\n\u003cth style=\"padding:10px 12px;text-align:left;border:1px solid #004a91;\"\u003ePanel\u003c\/th\u003e\n\u003cth style=\"padding:10px 12px;text-align:left;border:1px solid #004a91;\"\u003eMarkers Included\u003c\/th\u003e\n\u003cth style=\"padding:10px 12px;text-align:left;border:1px solid #004a91;\"\u003eClinical Rationale\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr style=\"background:#f5f8ff;\"\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003e\u003cstrong\u003eComplete Blood Count\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003eRBC, WBC with 5-part differential, platelets, haemoglobin, haematocrit, MCV, MCH, MCHC, RDW\u003c\/td\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003eDetects anaemia subtypes, infection\/immune dysfunction, haematological malignancy risk; RDW \u0026gt;14% independently predicts cardiovascular mortality\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"background:#fff;\"\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003e\u003cstrong\u003eComprehensive Metabolic Panel\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003eALT, AST, GGT, ALP, albumin, total protein, bilirubin, creatinine, eGFR, urea, electrolytes (Na\/K\/Cl\/CO2), glucose, HbA1c, uric acid\u003c\/td\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003eLiver synthetic function, renal filtration rate (KDIGO staging); HbA1c 39–47 mmol\/mol detects pre-diabetes; eGFR \u0026lt;60 mL\/min\/1.73m2 = CKD Stage 3\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"background:#f5f8ff;\"\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003e\u003cstrong\u003eAdvanced Thyroid Panel\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003eTSH (3rd generation, sensitivity 0.01 mIU\/L), free T3, free T4, anti-TPO antibodies, anti-thyroglobulin antibodies\u003c\/td\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003eAnti-TPO positivity predicts progression to overt hypothyroidism at ~4%\/year; subclinical hypothyroidism affects 8–10% of adults; free T3 correlates with metabolic rate and cardiac output\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"background:#fff;\"\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003e\u003cstrong\u003eHormonal Health Panel\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003eTotal testosterone (LC-MS\/MS), free testosterone (calculated), SHBG, oestradiol (E2), DHEA-S, IGF-1, cortisol (morning), LH, FSH\u003c\/td\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003eTestosterone \u0026lt;12 nmol\/L (men): 2.3× all-cause mortality; low DHEA-S correlates with accelerated immune ageing; IGF-1 regulates anabolic metabolism and tissue repair\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"background:#f5f8ff;\"\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003e\u003cstrong\u003eAdvanced Cardiovascular Panel\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003eTotal cholesterol, LDL-C, HDL-C, triglycerides, non-HDL-C, ApoB, Lp(a), hsCRP, homocysteine, fibrinogen\u003c\/td\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003eLp(a) \u0026gt;50 mg\/dL: 3× ASCVD risk; ApoB preferred over LDL-C per ACC\/AHA 2023; homocysteine \u0026gt;15 micromol\/L: 2× stroke risk; hsCRP \u0026gt;3 mg\/L: high inflammatory cardiovascular risk tier\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"background:#fff;\"\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003e\u003cstrong\u003eCancer Surveillance Markers\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003ePSA total + free ratio (men), CA-125 (women), CEA, AFP, CA 19-9, CA 15-3\u003c\/td\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003eInterpreted via trend and clinical context, not standalone diagnosis; PSA velocity and free\/total PSA ratio improve prostate cancer specificity; CEA elevated in colorectal and lung malignancy\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"background:#f5f8ff;\"\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003e\u003cstrong\u003eNutritional Status Panel\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003e25-OH Vitamin D3, B12, folate, serum iron, TIBC, ferritin, zinc, magnesium, selenium\u003c\/td\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003e25-OH D3 \u0026lt;50 nmol\/L affects 65–80% of Singapore adults; ferritin \u0026lt;30 microg\/L = pre-anaemic iron depletion; B12 \u0026lt;200 pmol\/L prevalent in vegetarians and metformin users\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"background:#fff;\"\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003e\u003cstrong\u003eInflammatory \u0026amp; Immune Markers\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003eESR, hsCRP, ferritin, immunoglobulins (IgG, IgA, IgM), complement C3\/C4, ANA screen (IIF, HEp-2 cells)\u003c\/td\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003eANA titre \u0026gt;1:160 with clinical features warrants reflex anti-dsDNA, anti-Sm, anti-Ro\/La testing; chronic low-grade inflammation underlies 7 of 10 leading causes of mortality\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"background:#f5f8ff;\"\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003e\u003cstrong\u003eUrinalysis \u0026amp; Stool Analysis\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003eUrine dipstick + microscopy (protein, blood, glucose, leucocytes, casts, microalbuminuria), FIT stool occult blood, H. pylori stool antigen\u003c\/td\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003eMicroalbuminuria 30–300 mg\/g predicts diabetic nephropathy 5–10 years pre-onset; FIT detects colorectal adenomas with 79% sensitivity; H. pylori eradication reduces gastric cancer risk 34%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"background:#fff;\"\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003e\u003cstrong\u003eNurse-Led Consultation\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003e45-minute one-on-one results review with EMIS+ registered nurse; personalised health optimisation plan\u003c\/td\u003e\n\u003ctd style=\"padding:9px 12px;border:1px solid #dde4f0;\"\u003eResults interpreted in context of health history, lifestyle, medications; triggers referral pathways; actionable 90-day health plan covering nutrition, exercise, supplementation, and monitoring\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eClinical Q\u0026amp;A: Essential Sentinel Screen\u003c\/h2\u003e\n\n\u003ch3\u003eWhy does the Essential Sentinel Screen include Lp(a) and ApoB when most screenings only measure LDL-C?\u003c\/h3\u003e\n\u003cp\u003eLDL-C (low-density lipoprotein cholesterol) is a concentration measure that underestimates cardiovascular risk in individuals with small, dense LDL particles or discordant ApoB levels. ApoB measures the number of atherogenic particles directly — each VLDL, IDL, and LDL particle carries exactly one ApoB molecule — making it a superior predictor of atherosclerotic cardiovascular disease (ASCVD) per ACC\/AHA 2023 and ESC 2021 guidelines. Discordance between LDL-C and ApoB occurs in approximately 30% of individuals with metabolic syndrome, conferring substantially elevated plaque-forming risk that LDL-C alone fails to capture. Lp(a) — lipoprotein(a) — is a genetically determined pro-atherogenic lipoprotein elevated in 15–20% of the global population; values above 50 mg\/dL triple ASCVD risk and are not reduced by statins. Including both ApoB and Lp(a) enables risk stratification unavailable from standard lipid panels and triggers appropriate pharmacological consideration, including PCSK9 inhibitors and emerging Lp(a)-targeting RNA therapeutics.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is the clinical significance of anti-TPO antibody testing in asymptomatic adults?\u003c\/h3\u003e\n\u003cp\u003eThyroid peroxidase antibodies (anti-TPO) are present in over 90% of Hashimoto's thyroiditis and 60–80% of Graves' disease. Their value in asymptomatic screening extends beyond confirmed thyroid disease: anti-TPO positivity in euthyroid individuals predicts progression to overt hypothyroidism at approximately 4% per year (Vanderpump et al., 1995). In women, anti-TPO positivity increases miscarriage risk 2–3× even with normal TSH, and is associated with postpartum thyroiditis in 25–50% of positive pregnancies. Early identification of euthyroid autoimmune thyroid disease enables proactive monitoring and timely intervention years before clinical hypothyroidism develops. Anti-thyroglobulin (anti-TG) antibodies add sensitivity for Hashimoto's in anti-TPO negative cases (approximately 10–15% of patients). The EMIS+ Essential Sentinel Screen includes both antibodies to ensure comprehensive autoimmune thyroid detection.\u003c\/p\u003e\n\n\u003ch3\u003eHow should cancer surveillance markers be interpreted in asymptomatic individuals?\u003c\/h3\u003e\n\u003cp\u003eCancer surveillance markers (CEA, AFP, CA 19-9, PSA, CA-125, CA 15-3) function as trend markers and risk stratifiers, not standalone diagnostic confirmations. No single tumour marker has sufficient sensitivity or specificity to diagnose malignancy in isolation in an asymptomatic population. PSA has 79% sensitivity and 68% specificity for prostate cancer at 4.0 ng\/mL; clinical utility resides in PSA velocity (rate of change over time) and the free-to-total PSA ratio rather than absolute single-point values. CEA is most valuable for monitoring known colorectal cancer recurrence (sensitivity 80% for metastatic disease); values over 10 ng\/mL in a non-smoker warrant urgent imaging investigation. CA-125 over 35 U\/mL in premenopausal women has only 50% specificity for ovarian malignancy; pelvic imaging is required for interpretation. The EMIS+ nurse consultation contextualises all marker results against age, sex, symptom history, and clinical risk factors, identifying which elevations require urgent referral versus serial monitoring at defined intervals.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is the ANA screen detecting and when does a positive titre require follow-up?\u003c\/h3\u003e\n\u003cp\u003eAntinuclear antibodies (ANA) are autoantibodies directed against cell-nucleus components. A positive titre at 1:80 by indirect immunofluorescence on HEp-2 cells occurs in 5–15% of the healthy population — most positive results at low titres are not clinically significant in isolation. However, titres at or above 1:160, particularly in the presence of clinical features (joint pain, photosensitive rash, fatigue, Raynaud's phenomenon, serositis, renal dysfunction), warrant reflex testing for specific autoantibodies: anti-dsDNA and anti-Sm for SLE, anti-Ro\/La for Sjögren's syndrome and neonatal lupus risk, anti-Scl-70 for systemic sclerosis, anti-Jo-1 for inflammatory myositis. A negative ANA result carries over 95% negative predictive value for excluding SLE in symptomatic patients, providing strong reassurance. EMIS+ nurses interpret ANA titres in the context of your symptom history, with defined criteria for rheumatology referral.\u003c\/p\u003e\n\n\u003ch3\u003eHow does the nutritional panel address Singapore-specific micronutrient deficiency patterns?\u003c\/h3\u003e\n\u003cp\u003eThree high-prevalence deficiencies documented in Singapore population surveys require proactive screening in all adults. Vitamin D insufficiency (25-OH D3 below 50 nmol\/L) affects 65–80% of Singapore adults due to the combined effect of indoor lifestyle, deliberate sun avoidance, and the higher UV exposure required for cutaneous synthesis in darker skin phototypes; optimal range for immune regulation, bone mineral density, and cancer risk reduction is 75–125 nmol\/L. Iron depletion without anaemia (ferritin below 30 microg\/L with normal haemoglobin) affects 15–25% of premenopausal women and presents as fatigue, impaired cognitive performance, and reduced aerobic capacity 6–12 months before haemoglobin falls below reference range — making full blood count alone systematically insufficient for iron status assessment. Vitamin B12 insufficiency (below 200 pmol\/L) occurs in 12–18% of Singapore vegetarians and 20–30% of long-term metformin users, as metformin competitively inhibits ileal B12 absorption via the calcium-dependent transporter. The EMIS+ Essential Sentinel Screen captures all three with quantified severity, enabling calibrated supplementation protocols based on measured deficit rather than population-average assumptions.\u003c\/p\u003e\n\n\u003cscript type=\"application\/ld+json\"\u003e{\"@context\":\"https:\/\/schema.org\",\"@type\":\"Product\",\"name\":\"Essential Sentinel Screen\",\"description\":\"EMIS+ premium comprehensive health screening — 80+ biomarkers across 9 organ system panels: CBC, metabolic, thyroid, hormonal, cardiovascular (ApoB\/Lp(a)), cancer surveillance, nutritional, inflammatory\/immune, urinalysis and stool. Includes 45-minute nurse-led consultation. ISO 15189:2022 accredited. Singapore.\",\"brand\":{\"@type\":\"Brand\",\"name\":\"EMIS+\"},\"offers\":{\"@type\":\"Offer\",\"priceCurrency\":\"SGD\",\"price\":\"1850.00\",\"availability\":\"https:\/\/schema.org\/InStock\",\"seller\":{\"@type\":\"Organization\",\"name\":\"Essential Medical International Supplies Pte Ltd\",\"url\":\"https:\/\/www.emis.asia\"}},\"additionalProperty\":[{\"@type\":\"PropertyValue\",\"name\":\"Total Biomarkers\",\"value\":\"80+ across 9 panel categories\"},{\"@type\":\"PropertyValue\",\"name\":\"Laboratory Standard\",\"value\":\"ISO 15189:2022 medical laboratory accreditation\"},{\"@type\":\"PropertyValue\",\"name\":\"Consultation Included\",\"value\":\"45-minute nurse-led clinical consultation\"},{\"@type\":\"PropertyValue\",\"name\":\"Cardiovascular Markers\",\"value\":\"ApoB, Lp(a), hsCRP, homocysteine\"},{\"@type\":\"PropertyValue\",\"name\":\"Cancer Markers\",\"value\":\"PSA, CA-125, CEA, AFP, CA 19-9, CA 15-3\"},{\"@type\":\"PropertyValue\",\"name\":\"Location\",\"value\":\"Singapore\"}]}\u003c\/script\u003e\n\n\u003cp\u003e\u003cstrong\u003eRegulatory \u0026amp; Standards Framework:\u003c\/strong\u003e All laboratory analyses performed under \u003cstrong\u003eISO 15189:2022\u003c\/strong\u003e (Medical laboratories — Requirements for quality and competence). Hormonal assays (testosterone LC-MS\/MS) validated per \u003cstrong\u003eCDC Hormone Standardisation (HoSt) Program\u003c\/strong\u003e reference standards. Thyroid function tests (TSH, free T3\/T4) referenced to \u003cstrong\u003eIFCC\/NACB Laboratory Medicine Practice Guidelines\u003c\/strong\u003e. Cardiovascular biomarkers (ApoB, Lp(a)) standardised to \u003cstrong\u003eWHO International Reference Preparations\u003c\/strong\u003e (IFCC Reference Material 2nd IS for Lp(a); WHO\/IFCC Reference Preparation SP3-07 for ApoB). Cancer marker methodology per \u003cstrong\u003eEGTM (European Group on Tumour Markers) guidelines\u003c\/strong\u003e. Anti-nuclear antibody testing by indirect immunofluorescence (IIF) on HEp-2 cells per \u003cstrong\u003eACR\/EULAR 2019 classification criteria\u003c\/strong\u003e. Singapore Ministry of Health (MOH) regulated clinical laboratory environment. \u003cstrong\u003eISO 22870:2016\u003c\/strong\u003e (Point-of-care testing) compliance maintained throughout.\u003c\/p\u003e\n\n\u003cscript type=\"application\/ld+json\"\u003e\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@type\": \"FAQPage\",\n  \"mainEntity\": [\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What are the benefits of Essential Sentinel Screen?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Essential Sentinel Screen by EMIS + supports general health and wellbeing as part of a balanced diet and healthy lifestyle. As with all supplements, individual results may vary. Consult your doctor or pharmacist before starting any new supplement, especially if you have existing medical conditions or are taking medications.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Who should take Essential Sentinel Screen?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Essential Sentinel Screen may be suitable for adults looking to support their health and address specific nutritional needs. It may be particularly beneficial for individuals with dietary gaps, those recovering from illness or surgery, or those with increased nutritional demands. Always consult a healthcare professional — your GP, pharmacist, or dietitian — before starting supplementation, especially during pregnancy, breastfeeding, or if you have a chronic condition.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What is the recommended dosage for Essential Sentinel Screen?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Follow the dosage instructions on the Essential Sentinel Screen product label or as directed by your healthcare provider. Do not exceed the recommended daily intake. If you experience any adverse reactions, discontinue use and consult a doctor. EMIS+ recommends consulting a Singapore-registered pharmacist or GP for personalised supplement advice.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Where can I buy Essential Sentinel Screen in Singapore?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Essential Sentinel Screen is available from EMIS+ at emis.asia with fast island-wide Singapore delivery. We stock a wide range of quality health supplements from trusted brands. Visit emis.asia or contact our team for product advice and bulk ordering.\"\n      }\n    }\n  ]\n}\n\u003c\/script\u003e","brand":"EMIS +","offers":[{"title":"Default Title","offer_id":43525775589454,"sku":null,"price":1850.0,"currency_code":"SGD","in_stock":true}],"url":"https:\/\/www.emis.asia\/products\/essential-sentinel-screen","provider":"EMIS +","version":"1.0","type":"link"}